Brachytherapy boost in anal canal cancer – A GEC ESTRO PDR task force meta-analysis (2023) Annede P, Ferre M, Kirisits C, Pieters BR, Schmid M, Strnad V, Westerveld H, Chargari C Journal article Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis (2023) Bodensohn R, Werner S, Reis J, Pazos Escudero M, Kaempfel AL, Hadi I, Forbrig R, et al. Journal article PD-1 and PD-L1 expression predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma (2022) Göbel HH, Distel L, Aigner T, Büttner-Herold M, Grabenbauer GG Journal article Endocrine therapy with accelerated Partial breast irradiatiOn or exclusive ultra-accelerated Partial breast irradiation for women aged >= 60 years with Early-stage breast cancer (EPOPE): The rationale for a GEC-ESTRO randomized phase III-controlled trial (2021) Hannoun-Levi JM, Chamorey E, Boulahssass R, Polgar C, Strnad V Journal article Definition and validation of a radiomics signature for loco-regional tumour control in patients with locally advanced head and neck squamous cell carcinoma (2021) Meneghetti AR, Zwanenburg A, Leger S, Leger K, Troost EGC, Linge A, Lohaus F, et al. Journal article RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial (2020) Martin D, Balermpas P, Gollrad J, Weiss C, Valentini C, Stuschke M, Schaefer H, et al. Journal article Cancer clinical trials – Survey evaluating patient participation and acceptance in a university-based Comprehensive Cancer Center (CCC) (2018) Kessel KA, Vogel MME, Kessel C, Bier H, Biedermann T, Friess H, Herschbach P, et al. Journal article SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy (2017) De-Colle C, Mönnich D, Welz S, Boeke S, Sipos B, Fend F, Mauz PS, et al. Journal article